Article

Pharmaceutical Executive

Witty Touts GSK Pipeline in 4th Quarter Review

Author(s):

Reid Paul

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Related Videos
Related Content
Stock.adobe.com
August 28th 2025

FDA Accepts New Drug Application for Gadoquatrane

Nicholas Jacobus
The Rx for High-Performance Leadership: Cutting Through the Chaos
August 28th 2025

The Rx for High-Performance Leadership: Cutting Through the Chaos

Michael Christel
Stock.adobe.com
August 28th 2025

ACOG Breaks From CDC, Reaffirms Support of Covid-19 Vaccine During Pregnancy

Nicholas Jacobus
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
August 28th 2025

Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research

Miranda Schmalfuhs
EVERSANA and Waltz Health Unite to Address Drug Pricing and Access Issues
August 28th 2025

EVERSANA and Waltz Health Unite to Address Drug Pricing and Access Issues

Nicholas Saraceno, Editor
Stock.adobe.com
August 28th 2025

Eli Lilly’s Orforglipron Successfully Completes Third Phase 3 Trial Resulting in Global Regulatory Submissions

Nicholas Jacobus